Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Ivacaftor Stories

2012-11-19 12:26:35

BETHESDA, Md., Nov. 19, 2012 /PRNewswire-USNewswire/ -- Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, today announced a major expansion of its research collaboration with Pfizer Inc. designed to discover new drugs to treat people with the most common mutation of CF, Delta F508. Under the new six-year pre-clinical research program with Pfizer, CFFT will invest up to $58 million to speed the...

2012-10-29 12:07:01

Scientists at the Hospital for Sick Children in Toronto have established that a drug recently approved by the U.S. Food and Drug Administration to treat a rare form of cystic fibrosis works in an unconventional way. Their results reveal new possibilities for treating various forms of cystic fibrosis. Cystic fibrosis is an inherited disease afflicting about 70,000 people around the world. Cystic fibrosis patients carry a defective gene that disables or destroys its protein product, which...

2012-10-25 11:23:36

First Drug to Treat the Cystic Fibrosis Defect was Developed in Collaboration With Cystic Fibrosis Foundation BETHESDA, Md., Oct. 25, 2012 /PRNewswire-USNewswire/ -- Kalydeco(TM), the first drug to treat the underlying cause of cystic fibrosis, has won The Wall Street Journal's 2012 Technology Innovation Award in the Medicine and Biotech category. The awards recognize technological breakthroughs that are game-changers or have a wide impact in their field and beyond. Kalydeco was...

2012-10-09 11:27:57

Conference Follows FDA Approval of Historic Drug to Treat Underlying Cause of CF - A Fatal Disease BETHESDA, Md., Oct. 9, 2012 /PRNewswire-USNewswire/ -- In the largest meeting of its kind, nearly 4,000 doctors, scientists and clinicians from diverse disciplines will meet in Orlando, Fla., Oct. 11 - 13, 2012, to present the latest advancements in cystic fibrosis research, care and drug development. Highlighted topics of the 26th annual North American Cystic Fibrosis Conference include:...